A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

Silicone wristbands could be more convenient option for collecting exposure data.

We are pleased to welcome 20 new joint appointees to PNNL.

Parallel graph neural networks identify protein-ligand 3-D structural interactions to aid in protein function prediction and drug discovery.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

Electrical engineer Aditya Ashok and cybersecurity researcher Thomas Edgar win best paper award for their work to create a new high-fidelity dataset that will help advance cybersecurity solutions for critical infrastructure protection.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

PNNL has received 119 R&D 100 Awards since 1969, when the laboratory began submitting entries in the contest that recognizes top 100 inventions each year.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.